Skip to playerSkip to main content
  • 11 years ago
Erlotinib targets the epidermal growth factor receptor (EGFR) tyrosine kinase. It is used in combination with gemcitabine for treating pancreatic cancer. For more: http://www.healthcare247.co/
Be the first to comment
Add your comment

Recommended